Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GALOP: Oral Glibenclamide in Premature Hyperglycemia
2024-512230-15-00Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of glibenclamide in Transient hyperglycemia of prematurity, sponsored by Assistance publique - Hôpitaux de Paris. Started May 2023; status: completed.
02
Drugs
glibenclamide
03
Conditions
Transient hyperglycemia of prematurity
Beyond the preview
Go deeper on 2024-512230-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512230-15-00.